The issue here is the material delays in enrolment. i accept that COVID may have played a role so not blaming the coy for the delay. however given the impact this has had on the share price and how important this first trial is to progressing the asset the ambiguous updates dont inspire confidence. Especially when shareholders have been asking for greater clarity.
Ann: Imagion Biosystems December 2021 Investor Newsletter, page-28
-
- There are more pages in this discussion • 38 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IBX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.285M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15322 | 6.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.0¢ | 25 | 1 |
View Market Depth
| Last trade - 10.04am 15/07/2024 (20 minute delay) ? |
| IBX (ASX) Chart |
Day chart unavailable